Literature DB >> 15461198

Prevalence, types and possible causes of insomnia in a Swiss remand prison.

Bernice S Elger1.   

Abstract

STUDY
OBJECTIVES: To determine the prevalence of insomnia complaints and possible causes among prisoners.
DESIGN: Prospective study of medical consultations during 1 year (questionnaire A) to identify reasons for consultation and diagnoses. After this year we compared the medical records (questionnaire B) of 112 non-substance misusing (NSM) insomniac prisoners identified through questionnaire A with the records of 103 NSM prisoners without insomnia complaint.
SETTING: Outpatient service of the remand prison in Geneva, Switzerland. PATIENTS: 995 prisoners.
INTERVENTIONS: None. MEASUREMENTS AND
RESULTS: The general practitioners returned completed questionnaires A for 92% (n = 2772) of the consultations (995 patients). Using questionnaire A and B, we identified 112 NSM insomnia patients. Among these, chronic forms of insomnia were more common than transitory insomnia (<3 weeks). The most frequently reported reason for insomnia was anxiety related to incarceration. A higher percentage of the 112 insomnia patients than of the 103 non-insomnia patients had a history of medical and psychiatric illness, suffered from anxiety or depression in prison, and received prescriptions of psychotropic and analgesic medications. After the study of the records, we estimated the overall prevalence of insomnia at 44.3% of the 995 patients of whom 51% (n = 223) were drug misusers.
CONCLUSIONS: Our results confirm that insomnia is a frequent complaint among prisoner patients and that at least half of insomnia patients are substance misusers. In NSM patients, insomnia does not seem to be an only transitory problem of adaptation to incarceration, but a more chronic problem lasting more than 3 weeks, related to a higher degree of medical and psychological problems before and during incarceration.

Entities:  

Mesh:

Year:  2004        PMID: 15461198     DOI: 10.1023/b:ejep.0000036805.58237.e3

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  34 in total

Review 1.  Management of insomnia.

Authors:  D J Kupfer; C F Reynolds
Journal:  N Engl J Med       Date:  1997-01-30       Impact factor: 91.245

2.  Psychiatric symptoms, cognitive stress and vulnerability factors. A study in a remand prison.

Authors:  T Harding; E Zimmermann
Journal:  Br J Psychiatry       Date:  1989-07       Impact factor: 9.319

3.  A comparison of two methods for examining inmates' self-reported drug use.

Authors:  K McElrath
Journal:  Int J Addict       Date:  1994-03

4.  A longitudinal study of prisoners on remand: psychiatric prevalence, incidence and psychopathology in solitary vs. non-solitary confinement.

Authors:  H S Andersen; D Sestoft; T Lillebaek; G Gabrielsen; R Hemmingsen; P Kramp
Journal:  Acta Psychiatr Scand       Date:  2000-07       Impact factor: 6.392

5.  Point prevalence of mental disorder in unconvicted male prisoners in England and Wales.

Authors:  D Brooke; C Taylor; J Gunn; A Maden
Journal:  BMJ       Date:  1996-12-14

6.  Biopsychobehavioral correlates of insomnia. IV: Diagnosis based on DSM-III.

Authors:  T L Tan; J D Kales; A Kales; C R Soldatos; E O Bixler
Journal:  Am J Psychiatry       Date:  1984-03       Impact factor: 18.112

7.  Prevalence and treatment of insomnia in general practice. A longitudinal study.

Authors:  F Hohagen; K Rink; C Käppler; E Schramm; D Riemann; S Weyerer; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

8.  The Zurich Study. VII. Insomnia: symptoms, classification and prevalence.

Authors:  J Angst; M Vollrath; R Koch; A Dobler-Mikola
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

9.  Substance misusers remanded to prison--a treatment opportunity?

Authors:  D Brooke; C Taylor; J Gunn; A Maden
Journal:  Addiction       Date:  1998-12       Impact factor: 6.526

Review 10.  Dopamine agonists for cocaine dependence.

Authors:  B G O Soares; M S Lima; A A P Reisser; M Farrell
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  8 in total

1.  Can morbidity be inferred from prescription drug use? Results from a nation-wide prison population study.

Authors:  Ellen Kjelsberg; Paal Hartvig
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Identity as an older prisoner: findings from a qualitative study in Switzerland.

Authors:  Sophie Haesen; Tenzin Wangmo; Bernice S Elger
Journal:  Eur J Ageing       Date:  2017-10-20

3.  Sleep quality and risk for sleep apnea in incarcerated women.

Authors:  Holly M Harner; Mia Budescu
Journal:  Nurs Res       Date:  2014 May-Jun       Impact factor: 2.381

4.  Mental health consultations in a prison population: a descriptive study.

Authors:  Ellen Kjelsberg; Paal Hartvig; Harald Bowitz; Irene Kuisma; Peder Norbech; Aase-Bente Rustad; Marthe Seem; Tom-Gunnar Vik
Journal:  BMC Psychiatry       Date:  2006-06-07       Impact factor: 3.630

5.  Exploring differences in healthcare utilization of prisoners in the Canton of Vaud, Switzerland.

Authors:  Karine Moschetti; Véra Zabrodina; Pierre Stadelmann; Tenzin Wangmo; Alberto Holly; Jean-Blaise Wasserfallen; Bernice S Elger; Bruno Gravier
Journal:  PLoS One       Date:  2017-10-30       Impact factor: 3.240

6.  Trouble sleeping inside: a cross-sectional study of the prevalence and associated risk factors of insomnia in adult prison populations in England.

Authors:  Lindsay H Dewa; Lamiece Hassan; Jenny J Shaw; Jane Senior
Journal:  Sleep Med       Date:  2017-01-16       Impact factor: 3.492

7.  Poor sleep quality and associated factors among prisoners of the Diredawa correctional facility in eastern Ethiopia.

Authors:  Yibeltal Getachew; Telake Azale; Mogesie Necho
Journal:  Ann Gen Psychiatry       Date:  2020-06-20       Impact factor: 3.455

8.  Sleep Quality and Psychological Status in a Group of Italian Prisoners.

Authors:  Giulia D'Aurizio; Angelica Caldarola; Marianna Ninniri; Marialucia Avvantaggiato; Giuseppe Curcio
Journal:  Int J Environ Res Public Health       Date:  2020-06-13       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.